Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Ataxin 10 anticorps (C-Term)

ATXN10 Reactivité: Humain, Rat, Souris IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN965623
  • Antigène Voir toutes Ataxin 10 (ATXN10) Anticorps
    Ataxin 10 (ATXN10)
    Épitope
    • 16
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reactivité
    • 32
    • 31
    • 24
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    Humain, Rat, Souris
    Hôte
    • 38
    • 3
    Lapin
    Clonalité
    • 41
    • 1
    Polyclonal
    Conjugué
    • 20
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp Ataxin 10 est non-conjugé
    Application
    • 32
    • 14
    • 13
    • 13
    • 9
    • 5
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    Immunohistochemistry (IHC)
    Purification
    Purified by antigen-specific affinity chromatography.
    Immunogène
    Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to C-terminal residues of human ATXN10(Ataxin-10)
    Top Product
    Discover our top product ATXN10 Anticorps primaire
  • Indications d'application
    ELISA, Western blotting: 1µg/ml for 2hrs.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    This antibody is stored in PBS, 50% glycerol
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
  • Matsuura, Fang, Pearson, Jayakar, Ashizawa, Roa, Nelson: "Interruptions in the expanded ATTCT repeat of spinocerebellar ataxia type 10: repeat purity as a disease modifier?" dans: American journal of human genetics, Vol. 78, Issue 1, pp. 125-9, (2005) (PubMed).

    Wiemann, Weil, Wellenreuther, Gassenhuber, Glassl, Ansorge, Böcher, Blöcker, Bauersachs, Blum, Lauber, Düsterhöft, Beyer, Köhrer, Strack, Mewes, Ottenwälder, Obermaier, Tampe, Heubner, Wambutt, Korn et al.: "Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs. ..." dans: Genome research, Vol. 11, Issue 3, pp. 422-35, (2001) (PubMed).

    Matsuura, Yamagata, Burgess, Rasmussen, Grewal, Watase, Khajavi, McCall, Davis, Zu, Achari, Pulst, Alonso, Noebels, Nelson, Zoghbi, Ashizawa: "Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10." dans: Nature genetics, Vol. 26, Issue 2, pp. 191-4, (2000) (PubMed).

  • Antigène
    Ataxin 10 (ATXN10)
    Autre désignation
    ATXN10 (ATXN10 Produits)
    Synonymes
    anticorps ATXN10, anticorps MGC97716, anticorps atxn10, anticorps Ataxin-10, anticorps si:dkeyp-15g12.2, anticorps E46L, anticorps HUMEEP, anticorps SCA10, anticorps Sca10, anticorps AI325283, anticorps C77170, anticorps E46, anticorps TEG-169, anticorps Tex169, anticorps ataxin 10, anticorps ATXN10, anticorps atxn10, anticorps Atxn10
    Sujet
    The autosomal dominant cerebellar ataxias (ADCAs) are a clinically and genetically heterogeneous group of disorders characterized by ataxia, dysarthria, dysmetria, and intention tremor. All ADCAs involve some degree of cerebellar dysfunction and a varying degree of signs from other components of the nervous system. Defects in ATXN10 are the cause of spinocerebellar ataxia type 10. SCA10 is an autosomal dominant disorder and is predominantly characterized by cerebellar ataxia seizures. In addition patients often show soft pyramidal signs, ocular dyskinesia, cognitive impairment, and/or behavioral disturbances. SCA10 has been recognized only in families of Mexican origin. The molecular basis of the disease is due to an ATTCT nucleotide repeat expansion in intron 9.
Vous êtes ici:
Support technique